BioCentury
ARTICLE | Clinical News

Aczone regulatory update

September 6, 2004 7:00 AM UTC

The partners submitted an NDA for Aczone 5% dapsone gel to treat acne. ATRX is being acquired by QLT Inc. (TSE:QLT; QLTI, Vancouver, B.C.) (see BioCentury, June 21). ...